Delbios seeks to subcontract expert services to conduct a CMC and Non-clinical Gap Analysis, providing technical, regulatory, and scientific input to consolidate the nanoGLA development[…]
In the preclinical development of the nanoGLA it has been a requirement the assessment of anti-drug antibodies production in preclinical species. Currently we request the[…]
In the preclinical development of the nanoGLA it has been a requirement the assessment of anti-drug antibodies production in preclinical species. We request the development[…]
As part of the preclinical development plan, we require the development and validation of a bioanalytical method to perform bioanalysis of toxicological programme supporting a[…]